Nystatin A3 is a lipid of Polyketides (PK) class. Nystatin a3 is associated with abnormalities such as Mycoses, Candidiasis of the genitals and Gigantism. The involved functions are known as Drug Interactions, Process, Synthesis, Fermentation and Anabolism. Nystatin a3 often locates in Cell membrane, Membrane, Protoplasm, Entire oral cavity and integral to membrane. The associated genes with Nystatin A3 are Gene Clusters. The related lipids are Sterols, 1,2-oleoylphosphatidylcholine, Membrane Lipids, DOPE and N-caproylsphingosine.
To understand associated biological information of Nystatin A3, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
Nystatin A3 is suspected in Mycoses, Candidiasis of the genitals, Gigantism and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with Nystatin A3
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
There are no associated biomedical information in the current reference collection.
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
Ramaswamy M et al. | Species differences in the proportion of plasma lipoprotein lipid carried by high-density lipoproteins influence the distribution of free and liposomal nystatin in human, dog, and rat plasma. | 1999 | Antimicrob. Agents Chemother. | pmid:10348764 |
Mehta RT et al. | Formulation, toxicity, and antifungal activity in vitro of liposome-encapsulated nystatin as therapeutic agent for systemic candidiasis. | 1987 | Antimicrob. Agents Chemother. | pmid:3439798 |
Mehta RT et al. | Toxicity and therapeutic effects in mice of liposome-encapsulated nystatin for systemic fungal infections. | 1987 | Antimicrob. Agents Chemother. | pmid:3439799 |
Ostrosky-Zeichner L et al. | Differential antifungal activity of isomeric forms of nystatin. | 2001 | Antimicrob. Agents Chemother. | pmid:11557469 |
Clements-Jewery S | Nystatin-induced potassium efflux from Saccharomyces cerevisiae measured by flame photometry: a potential bioassay approach. | 1976 | Antimicrob. Agents Chemother. | pmid:773299 |
Hsuchen CC and Feingold DS | Selective membrane toxicity of the polyene antibiotics: studies on natural membranes. | 1973 | Antimicrob. Agents Chemother. | pmid:4586145 |
Hsuchen CC and Feingold DS | Selective membrane toxicity of the polyene antibiotics: studies on lecithin membrane models (liposomes). | 1973 | Antimicrob. Agents Chemother. | pmid:4758835 |
Badaracco G and Cassani G | Ribonucleic acid synthesis dependent on exogenous triphosphates in nystatin-treated cells of of Kluyveromyces latis. | 1976 | Antimicrob. Agents Chemother. | pmid:949173 |
Flattery AM et al. | New model of oropharyngeal and gastrointestinal colonization by Candida albicans in CD4+ T-cell-deficient mice for evaluation of antifungal agents. | 1996 | Antimicrob. Agents Chemother. | pmid:8807048 |
Akiyama S et al. | Classification of polyene antibiotics according to their synergistic effect in combination with bleomycin A2 or fusidic acid. | 1980 | Antimicrob. Agents Chemother. | pmid:6160808 |
Oakley KL et al. | Comparison of in vitro activity of liposomal nystatin against Aspergillus species with those of nystatin, amphotericin B (AB) deoxycholate, AB colloidal dispersion, liposomal AB, AB lipid complex, and itraconazole. | 1999 | Antimicrob. Agents Chemother. | pmid:10223948 |
Retamales P et al. | Complementation analysis with new genetic markers in Phaffia rhodozyma. | 1998 | Antonie Van Leeuwenhoek | pmid:9801767 |
Kovalchik MT and Kraus SJ | Neisseria gonorrhoeae: colonial morphology of rectal isolates. | 1972 | Appl Microbiol | pmid:4624216 |
Patel PV and Johnston JR | Dominant mutation for nystatin resistance in yeast. | 1968 | Appl Microbiol | pmid:5636460 |
Huhtanen CN and Pensack JM | Effect of antifungal compounds on aspergillosis in hatching chick embryos. | 1967 | Appl Microbiol | pmid:5298442 |
Merkal RS and Richards WD | Inhibition of fungal growth in the cultural isolation of mycobacteria. | 1972 | Appl Microbiol | pmid:4561102 |
Plourde R and Hafez-Zedan H | Distribution of steroid 1-dehydrogenation and side-chain degradation enzymes in the spores of Fusarium solani: causes of metabolic lag and carbohydrate independence. | 1973 | Appl Microbiol | pmid:4699223 |
James AN et al. | Variation in colonial morphology of Neisseria gonorrhoeae after growth on media containing antimicrobial agents. | 1973 | Appl Microbiol | pmid:4201640 |
Wang W et al. | The interaction of polysaccharide from Auricularia polytricha with quantum dots and the protection of plasmid DNA from damage. | 2013 | Appl. Biochem. Biotechnol. | pmid:23440638 |
Sanchez S et al. | Selective enrichment of aromatic amino acid auxotrophs in Hansenula polymorpha. | 1978 | Appl. Environ. Microbiol. | pmid:345964 |
Volokhan O et al. | Characterization of the P450 monooxygenase NysL, responsible for C-10 hydroxylation during biosynthesis of the polyene macrolide antibiotic nystatin in Streptomyces noursei. | 2006 | Appl. Environ. Microbiol. | pmid:16597951 |
Nedal A et al. | Analysis of the mycosamine biosynthesis and attachment genes in the nystatin biosynthetic gene cluster of Streptomyces noursei ATCC 11455. | 2007 | Appl. Environ. Microbiol. | pmid:17905880 |
Gleeson MA et al. | Isolation of Candida tropicalis auxotrophic mutants. | 1990 | Appl. Environ. Microbiol. | pmid:2206102 |
Brautaset T et al. | New nystatin-related antifungal polyene macrolides with altered polyol region generated via biosynthetic engineering of Streptomyces noursei. | 2011 | Appl. Environ. Microbiol. | pmid:21764946 |
Kasbekar DP and Papavinasasundaram KG | An inducible, nondegradative phytoalexin resistance mechanism in Dictyostelium discoideum is suppressed by mutations that alter membrane sterol composition. | 1992 | Appl. Environ. Microbiol. | pmid:1622285 |
Shobayashi M et al. | A new method for isolation of S-adenosylmethionine (SAM)-accumulating yeast. | 2006 | Appl. Microbiol. Biotechnol. | pmid:16010571 |
Kim HJ et al. | Redesign of antifungal polyene glycosylation: engineered biosynthesis of disaccharide-modified NPP. | 2017 | Appl. Microbiol. Biotechnol. | pmid:28488115 |
Lee MJ et al. | Structural analysis and biosynthetic engineering of a solubility-improved and less-hemolytic nystatin-like polyene in Pseudonocardia autotrophica. | 2012 | Appl. Microbiol. Biotechnol. | pmid:22382166 |
Walmsley S et al. | Engineered biosynthesis and characterisation of disaccharide-modified 8-deoxyamphoteronolides. | 2017 | Appl. Microbiol. Biotechnol. | pmid:27858138 |
Fjaervik E and Zotchev SB | Biosynthesis of the polyene macrolide antibiotic nystatin in Streptomyces noursei. | 2005 | Appl. Microbiol. Biotechnol. | pmid:15700127 |
SPENCER MC | CLINICAL LIMITATIONS OF EXPERIMENTAL CUTANEOUS MONILIASIS (CANDIDA ALBICANS). | 1963 | Arch Dermatol | pmid:14071472 |
Coskey RJ | Contact dermatitis due to nystatin. | 1971 | Arch Dermatol | pmid:5552354 |
Stroud JD and Van Dersarl JV | Striae. | 1971 | Arch Dermatol | pmid:5539499 |
Rudolph N et al. | Congenital cutaneous candidiasis. | 1977 | Arch Dermatol | pmid:889338 |
Marples RR et al. | Topical steroid-antibiotic combinations: assay of use in experimentally induced human infections. | 1973 | Arch Dermatol | pmid:4579498 |
Bradford LG and Montes LF | Perioral dermatitis and Candida albicans. | 1972 | Arch Dermatol | pmid:4555327 |
Tio TH et al. | Subcutaneous phycomycosis. | 1966 | Arch Dermatol | pmid:5940919 |
Garty BZ | Stevens-Johnson syndrome associated with nystatin treatment. | 1991 | Arch Dermatol | pmid:1827246 |
Coskey RJ and Bryan HG | Letter: Contact dermatitis due to perfume in Mycolog cream. | 1975 | Arch Dermatol | pmid:47237 |
Stritzler C | Cutaneous candidiasis treated with topical amphotericin B. A comparative study. | 1966 | Arch Dermatol | pmid:5900690 |
Chalmers D | Letter: Subclinical infection. | 1974 | Arch Dermatol | pmid:4852939 |
Maize JC and Lynch PJ | Chronic mucocutaneous candidiasis of the adult. A report of a patient with an associated thymoma. | 1972 | Arch Dermatol | pmid:5009626 |
Wasilewski C | Allergic contact dermatitis from nystatin. | 1971 | Arch Dermatol | pmid:5114421 |
Chalmers D | Contact dermatitis due to nystatin. | 1971 | Arch Dermatol | pmid:5114422 |
Coskey RJ and Paul L | Ampicillin sensitivity in infectious mononucleosis. | 1969 | Arch Dermatol | pmid:4312379 |
Porter PS and Lyle JS | Yeast vulvovaginitis due to oral contraceptives. | 1966 | Arch Dermatol | pmid:5862627 |
Petrozzi JW and Witkowski JA | Acrodermatitis perstans. Generalization following therapy with nystatin. | 1971 | Arch Dermatol | pmid:5091870 |
Crutcher N et al. | Oral nystatin in the treatment of psoriasis. | 1984 | Arch Dermatol | pmid:6703746 |
Wasilewski C | Allergic contact dermatitis from nystatin. | 1970 | Arch Dermatol | pmid:5430317 |
Carter VH and Olansky S | Haloprogin and nystatin therapy for cutaneous candidiasis. Comparison of the efficacy of haloprogin and nystatin therapy. | 1974 | Arch Dermatol | pmid:4608934 |